Du sökte efter promore pharma - BioStock

BioStock lists the strongest and the weakest stocks in life science of 2023.

2023’s strongest and weakest life science stocks

9 January, 2024

Promore carries out reverse takeover

Promore carries out reverse acquisition and changes its operations

29 November, 2023

Patent och studie i fokus för Promore Pharma

Patents and study in focus for Promore Pharma

22 March, 2023

Promore Pharma’s CEO on hopes for 2023

10 January, 2023

Promore Pharmas kvartalsrapport Q2

Promore Pharma advancing according to plan

5 September, 2022

Patent Promore Pharma

Promore Pharma strengthens IP-protection

15 August, 2022

Promore Pharma fas II-studie

Last clinic visit completed in Promore Pharma’s ensereptide study

17 June, 2022

Promore Pharmas Q1 studieavancemang

Promore Pharma’s Q1 characterised by study progress

25 May, 2022

Promore Pharma leg wounds

Promore Pharma aims to accelerate healing of venous leg ulcers

16 May, 2022

Promore Pharma’s phase II study running according to plan

7 April, 2022

BIoStock Investor Meeting 16 mars

BioStock Investor Meeting 16 March

16 March, 2022

Promore Pharma initiates patient recruitment

21 February, 2022

BioStock investor meeting March 16

BioStock Investor Meeting, March 16

27 January, 2022

Promore Pharma prepares phase II study

20 January, 2022